GSK停止慢性咳嗽药物开发
2026-07-17 11:07:54
据彭博社报道，葛兰素史克(GSK)已停止一款慢性咳嗽实验性药物的开发，此前试验结果喜忧参半，公司称该药“不太可能改变患者护理”。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
AI企业正分散模型依赖Next article：
晶门半导体料上半年亏损最多410万美元
